Adapthealth Corp
NASDAQ:AHCO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.49
11.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AHCO stock under the Base Case scenario is 28.01 USD. Compared to the current market price of 10.32 USD, Adapthealth Corp is Undervalued by 63%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Adapthealth Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AHCO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Adapthealth Corp
Balance Sheet Decomposition
Adapthealth Corp
Current Assets | 683.8m |
Cash & Short-Term Investments | 100.2m |
Receivables | 401.2m |
Other Current Assets | 182.4m |
Non-Current Assets | 3.8B |
PP&E | 620.1m |
Intangibles | 2.8B |
Other Non-Current Assets | 345.3m |
Current Liabilities | 553m |
Accounts Payable | 357.8m |
Accrued Liabilities | 102.8m |
Other Current Liabilities | 92.4m |
Non-Current Liabilities | 2.4B |
Long-Term Debt | 2B |
Other Non-Current Liabilities | 360.9m |
Earnings Waterfall
Adapthealth Corp
Revenue
|
4.1B
USD
|
Cost of Revenue
|
-3.3B
USD
|
Gross Profit
|
756.5m
USD
|
Operating Expenses
|
-400.6m
USD
|
Operating Income
|
355.9m
USD
|
Other Expenses
|
-575.6m
USD
|
Net Income
|
-219.7m
USD
|
Free Cash Flow Analysis
Adapthealth Corp
USD | |
Free Cash Flow | USD |
AHCO Profitability Score
Profitability Due Diligence
Adapthealth Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Adapthealth Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
AHCO Solvency Score
Solvency Due Diligence
Adapthealth Corp's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Score
Adapthealth Corp's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AHCO Price Targets Summary
Adapthealth Corp
According to Wall Street analysts, the average 1-year price target for AHCO is 12.69 USD with a low forecast of 9.6 USD and a high forecast of 16.8 USD.
Dividends
Current shareholder yield for AHCO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 10,700 full-time employees. The company went IPO on 2018-02-21. The firm is focused on providing sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps); home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The breadth of the Company’s product is particularly valuable to acute care hospitals, sleep laboratories and long-term care facilities that discharge patients with complex conditions and multiple product needs.
Contact
IPO
Employees
Officers
The intrinsic value of one AHCO stock under the Base Case scenario is 28.01 USD.
Compared to the current market price of 10.32 USD, Adapthealth Corp is Undervalued by 63%.